Kojin Therapeutics

Kojin Therapeutics is a biotechnology company focused on developing small-molecule medicines that modulate ferroptosis, a specific type of cell death.

Their innovative approach targets refractory cancers and inflammatory diseases, aiming to provide effective treatments for challenging medical conditions. The company is driven by a team of dedicated scientists who specialize in cell-state and ferroptosis biology. They foster a collaborative environment that encourages groundbreaking scientific advancements. Kojin Therapeutics is committed to creating therapies for patients with difficult-to-treat cancers, autoimmune diseases, and inflammatory conditions.